Quinn JE - Search Results

1

Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms.

Quinn JE, Brown LG, Zhang J, Keller ET, Vessella RL, Corey E. Quinn JE, et al. Prostate Cancer Prostatic Dis. 2005;8(3):253-9. doi: 10.1038/sj.pcan.4500815. Prostate Cancer Prostatic Dis. 2005. PMID: 15999121

2

Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells.

Corey E, Quinn JE, Bladou F, Brown LG, Roudier MP, Brown JM, Buhler KR, Vessella RL. Corey E, et al. Among authors: quinn je. Prostate. 2002 Jun 1;52(1):20-33. doi: 10.1002/pros.10091. Prostate. 2002. PMID: 11992617

3

Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.

Corey E, Brown LG, Quinn JE, Poot M, Roudier MP, Higano CS, Vessella RL. Corey E, et al. Among authors: quinn je. Clin Cancer Res. 2003 Jan;9(1):295-306. Clin Cancer Res. 2003. PMID: 12538482

4

LuCaP 35: a new model of prostate cancer progression to androgen independence.

Corey E, Quinn JE, Buhler KR, Nelson PS, Macoska JA, True LD, Vessella RL. Corey E, et al. Among authors: quinn je. Prostate. 2003 Jun 1;55(4):239-46. doi: 10.1002/pros.10198. Prostate. 2003. PMID: 12712403

5

A novel method of generating prostate cancer metastases from orthotopic implants.

Corey E, Quinn JE, Vessella RL. Corey E, et al. Among authors: quinn je. Prostate. 2003 Jul 1;56(2):110-4. doi: 10.1002/pros.10235. Prostate. 2003. PMID: 12746835

6

Characterization of C4-2 prostate cancer bone metastases and their response to castration.

Pfitzenmaier J, Quinn JE, Odman AM, Zhang J, Keller ET, Vessella RL, Corey E. Pfitzenmaier J, et al. Among authors: quinn je. J Bone Miner Res. 2003 Oct;18(10):1882-8. doi: 10.1359/jbmr.2003.18.10.1882. J Bone Miner Res. 2003. PMID: 14584899 Free article.

7

Osteoprotegerin in prostate cancer bone metastasis.

Corey E, Brown LG, Kiefer JA, Quinn JE, Pitts TE, Blair JM, Vessella RL. Corey E, et al. Among authors: quinn je. Cancer Res. 2005 Mar 1;65(5):1710-8. doi: 10.1158/0008-5472.CAN-04-2033. Cancer Res. 2005. PMID: 15753366

8

The effect of osteoprotegerin administration on the intra-tibial growth of the osteoblastic LuCaP 23.1 prostate cancer xenograft.

Kiefer JA, Vessella RL, Quinn JE, Odman AM, Zhang J, Keller ET, Kostenuik PJ, Dunstan CR, Corey E. Kiefer JA, et al. Among authors: quinn je. Clin Exp Metastasis. 2004;21(5):381-7. doi: 10.1007/s10585-004-2869-0. Clin Exp Metastasis. 2004. PMID: 15672862 Free article.

9

Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiol.

Corey E, Quinn JE, Emond MJ, Buhler KR, Brown LG, Vessella RL. Corey E, et al. Among authors: quinn je. Clin Cancer Res. 2002 Apr;8(4):1003-7. Clin Cancer Res. 2002. PMID: 11948106

10

Molecular characterization of prostatic small-cell neuroendocrine carcinoma.

Clegg N, Ferguson C, True LD, Arnold H, Moorman A, Quinn JE, Vessella RL, Nelson PS. Clegg N, et al. Among authors: quinn je. Prostate. 2003 Apr 1;55(1):55-64. doi: 10.1002/pros.10217. Prostate. 2003. PMID: 12640661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters